微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | -173% | -1008.97% | -36.65% | 66/69 | 3.08% | 天目药业 | 9.27% | 行业排名> |
| 2024-06-30 | -126.6% | -904.76% | -356.71% | 67/69 | 0.67% | 天目药业 | 22.26% | 行业排名> |
| 2024-03-31 | -27.72% | -852.58% | 78.17% | 66/69 | 1.53% | 羚锐制药 | 20.44% | 行业排名> |
| 2023-12-31 | -127.01% | -5281.78% | -714.17% | 66/69 | 0.11% | 羚锐制药 | 13.25% | 行业排名> |
| 2023-09-30 | -15.6% | -578.53% | -23.81% | 66/69 | 7.26% | 片仔癀 | 7.03% | 行业排名> |
| 2023-06-30 | -12.6% | -135.96% | -332.99% | 66/69 | 4.93% | 片仔癀 | 23.1% | 行业排名> |
| 2023-03-31 | -2.91% | -265.34% | -23.31% | 66/69 | 3.21% | 太极集团 | 22.08% | 行业排名> |
| 2022-12-31 | -2.36% | -137.28% | -172.39% | 58/69 | 6.65% | 太极集团 | 17.13% | 行业排名> |
| 2022-09-30 | 3.26% | -72.18% | 161.05% | 48/69 | 5.16% | 以岭药业 | 10.43% | 行业排名> |
| 2022-06-30 | -5.34% | -156.69% | -403.41% | 65/69 | 3.2% | *ST吉药 | 72.63% | 行业排名> |
| 2022-03-31 | 1.76% | -76.12% | -72.2% | 42/69 | 2.18% | 片仔癀 | 23.54% | 行业排名> |
| 2021-12-31 | 6.33% | 233.16% | -45.99% | 37/69 | 4.54% | 片仔癀 | 19.69% | 行业排名> |
| 2021-09-30 | 11.72% | 10554.55% | 24.42% | 14/69 | 7.54% | 片仔癀 | 12.75% | 行业排名> |
| 2021-06-30 | 9.42% | 644.51% | 27.82% | 6/69 | 4.68% | 片仔癀 | 6.88% | 行业排名> |
| 2021-03-31 | 7.37% | 1288.71% | 287.89% | 1/69 | 2.7% | 片仔癀 | 27.39% | 行业排名> |
| 2020-12-31 | 1.9% | 103.08% | 1627.27% | 56/69 | 0.1% | 片仔癀 | 23.14% | 行业排名> |
| 2020-09-30 | 0.11% | -94.15% | 106.36% | 62/69 | 6.79% | 片仔癀 | 13.23% | 行业排名> |
| 2020-06-30 | -1.73% | -158.45% | -179.03% | 63/69 | 3.75% | *ST长药 | 7.37% | 行业排名> |
| 2020-03-31 | -0.62% | -135.84% | 99% | 62/69 | 2.14% | 沃华医药 | 22.84% | 行业排名> |
| 2019-12-31 | -61.78% | -1046.1% | -3386.17% | 67/69 | 5.86% | 沃华医药 | 19.47% | 行业排名> |
| 2019-09-30 | 1.88% | -76.14% | -36.49% | 58/69 | 7.3% | 沃华医药 | 12.7% | 行业排名> |
| 2019-06-30 | 2.96% | -27.8% | 71.1% | 46/69 | 4.72% | 济川药业 | 7.33% | 行业排名> |
| 2019-03-31 | 1.73% | 58.72% | -73.51% | 47/69 | 2.92% | 济川药业 | 27.43% | 行业排名> |
| 2018-12-31 | 6.53% | -23.63% | -17.13% | 44/69 | 7.87% | 济川药业 | 23.05% | 行业排名> |
| 2018-09-30 | 7.88% | -2.23% | 92.2% | 31/69 | 8.02% | 济川药业 | 15.79% | 行业排名> |
| 2018-06-30 | 4.1% | -25.59% | 276.15% | 39/69 | 5.03% | 华润三九 | 10.23% | 行业排名> |
| 2018-03-31 | 1.09% | 84.75% | -87.25% | 50/69 | 2.75% | 济川药业 | 32.79% | 行业排名> |
| 2017-12-31 | 8.55% | 1009.57% | 6.08% | 40/69 | 9.93% | 济川药业 | 27.55% | 行业排名> |
| 2017-09-30 | 8.06% | 560.66% | 46.28% | 33/69 | 8.39% | 济川药业 | 17.62% | 行业排名> |
| 2017-06-30 | 5.51% | 540.8% | 833.9% | 31/69 | 5.24% | 济川药业 | 10.07% | 行业排名> |
| 2017-03-31 | 0.59% | 59.46% | 162.77% | 54/69 | 2.62% | ST葫芦娃 | 46.01% | 行业排名> |
| 2016-12-31 | -0.94% | -34.29% | -177.05% | 62/69 | 10.02% | 济川药业 | 24.2% | 行业排名> |
| 2016-09-30 | 1.22% | 493.55% | 197.6% | 55/69 | 9.32% | *ST大药 | 15.31% | 行业排名> |
| 2016-06-30 | -1.25% | -201.63% | -437.84% | 60/69 | 5.04% | 济川药业 | 14.64% | 行业排名> |
| 2016-03-31 | 0.37% | 94.74% | 152.86% | 53/69 | 4.1% | 济川药业 | 7.64% | 行业排名> |
| 2015-12-31 | -0.7% | -108.94% | -125.81% | 60/69 | 11.34% | 维康药业 | 38.23% | 行业排名> |
| 2015-09-30 | -0.31% | -104.39% | -125.2% | 52/69 | 8.44% | 太极集团 | 58.41% | 行业排名> |
| 2015-06-30 | 1.23% | -79.87% | 547.37% | 49/69 | 5.48% | 新光药业 | 16.54% | 行业排名> |
| 2015-03-31 | 0.19% | -90.1% | -97.57% | 51/69 | 2.9% | 太极集团 | 71.6% | 行业排名> |